ProCE Banner Activity

ACC.20/WCC Virtual: Key Studies on Heart Failure Treatment

Conference Coverage
Clinical Thought
Here are the key studies from the ACC.20/WCC Virtual conference that will influence my treatment of patients with heart failure.

Released: April 17, 2020

Expiration: April 16, 2021

No longer available for credit.

Share

Faculty

Akshay Suvas Desai

Akshay Suvas Desai, MD, MPH

Associate Professor of Medicine
Department of Cardiovascular Medicine
Center for Advanced Heart Disease
Harvard Medical School
Director, Heart Failure Disease Management Program
Brigham and Womens Hospital
Boston, Massachusetts

Faculty Disclosure

Primary Author

Akshay Suvas Desai, MD, MPH

Associate Professor of Medicine
Department of Cardiovascular Medicine
Center for Advanced Heart Disease
Harvard Medical School
Director, Heart Failure Disease Management Program
Brigham and Womens Hospital
Boston, Massachusetts

Dr. Desai has disclosed that he has received funds for research support from Abbott, Alnylam, AstraZeneca, Bayer, and Novartis and consulting fees from Abbott, Amgen, Alnylam, AstraZeneca, Bayer, Boston Scientific, Boehringer Ingelheim, Biofourmis, Corvidia, DalCor Pharma, Merck, Novartis, Regeneron, and Relypsa.